ADAKVEO is a prescription medicine used in people 16 years of age and older who have sickle cell disease to help reduce frequency of painful episodes

Administration and Dosage:

Administration of ADAKVEO® follows a 5 mg/kg by intravenous infusion over a period of 30 minutes on Week 0, Week 2, and every 4 weeks thereafter.

Common Side Effects:

Most common adverse reactions (incidence > 10%) are nausea, arthralgia, back pain, abdominal pain, and pyrexia.

More Information:

Please see full Prescribing Information including Patient Information.

Ready to Schedule an Appointment?

Please CLICK HERE to get started.


ADAKVEO is a selectin blocker indicated to reduce the frequency of vasoocclusive crises in adults and pediatric patients aged 16 years and older with sickle cell disease.